Summit Therapeutics (NASDAQ:SMMT – Get Free Report) released its earnings results on Thursday. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01), Zacks reports. Here are the key takeaways from Summit Therapeutics’ conference call: Updated HARMONi OS data showed a hazard ratio of 0.76 in both […]

Summit Therapeutics PLC (NASDAQ:SMMT – Get Free Report)’s stock price gapped down prior to trading on Friday following a dissappointing earnings announcement. The stock had previously closed at $14.98, but opened at $13.72. Summit Therapeutics shares last traded at $13.5480, with a volume of 1,571,258 shares trading hands. The company reported ($0.28) earnings per share […]